MétaCan
Menu
Back to cohort
Record W2026619114 · doi:10.1136/bmjopen-2014-004842

Steroids In caRdiac Surgery (SIRS) trial: acute kidney injury substudy protocol of an international randomised controlled trial

2014· article· en· W2026619114 on OpenAlexafffundabout
Amit X. Garg, Jessica Vincent, Meaghan S. Cuerden, Chirag R. Parikh, P.J. Devereaux, Kevin Teoh, Salim Yusuf, Ainslie Hildebrand, André Lamy, Yunxia Zuo, Daniel I. Sessler, Pallav Shah, Seyed Hesameddin Abbasi, Mackenzie Quantz, Jean-Pierre Yared, Nicolas Noiseux, Georgios Tagarakis, Antoine Rochon, Janice Pogue, Michael Walsh, Matthew T.V. Chan, François Lamontagne, Abbas Salehiomran, Richard Whitlock

Bibliographic record

VenueBMJ Open · 2014
Typearticle
Languageen
FieldMedicine
TopicAcute Kidney Injury Research
Canadian institutionsMontreal Heart InstituteCentre Hospitalier de l’Université de MontréalHamilton Health SciencesUniversity of WaterlooUniversité de SherbrookeMcMaster UniversityPopulation Health Research InstituteWestern University
FundersCanadian Institutes of Health Research
KeywordsMedicineAcute kidney injuryCreatininePerioperativeCardiac surgeryKidney diseaseRenal functionPlaceboMethylprednisoloneRandomized controlled trialVascular surgeryInternal medicineSurgery

Abstract

fetched live from OpenAlex

INTRODUCTION: Steroids In caRdiac Surgery trial (SIRS) is a large international randomised controlled trial of methylprednisolone or placebo in patients undergoing cardiac surgery with the use of a cardiopulmonary bypass pump. At the time of surgery, compared with placebo, methylprednisolone divided into two intravenous doses of 250 mg each may reduce the risk of postoperative acute kidney injury (AKI). METHODS AND ANALYSIS: With respect to the study schedule, over 7000 substudy eligible patients from 81 centres in 18 countries were randomised in December 2013. The authors will use a logistic regression to estimate the adjusted OR of methylprednisolone versus placebo on the primary outcome of AKI in the 14 days following surgery (a postoperative increase in serum creatinine of ≥50%, or ≥26.5 μmol/L, from the preoperative value). The stage of AKI will also be considered, as will the outcome of AKI in those with and without preoperative chronic kidney disease. After receipt of grant funding, the authors began to record additional perioperative serum creatinine measurements in consecutive patients enrolled at substudy participating centres, and patients were invited to enroll in a 6-month serum creatinine collection. In these trial subpopulations, the authors will consider the outcome of AKI defined in alternate ways, and the outcome of a 6-month change in kidney function from the preoperative value. ETHICS AND DISSEMINATION: The authors were competitively awarded a grant from the Canadian Institutes of Health Research for this SIRS AKI substudy. Ethics approval was obtained for additional serum creatinine recordings in consecutive patients enrolled at participating centres. The additional kidney data collection first began for patients enrolled after 1 March 2012. In patients who provided consent, the last 6-month kidney outcome data will be collected in 2014. The results will be reported no later than 2015. CLINICAL TRIAL REGISTRATION: Number NCT00427388.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.045
metaresearch head score (Gemma)0.049
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.052
Threshold uncertainty score0.238

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0450.049
Meta-epidemiology (narrow)0.0070.003
Meta-epidemiology (broad)0.0120.007
Bibliometrics0.0020.005
Science and technology studies0.0040.005
Scholarly communication0.0070.005
Open science0.0040.003
Research integrity0.0090.010
Insufficient payload (model declined to judge)0.0520.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.083
GPT teacher head0.471
Teacher spread0.388 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2014
Admission routes3
Has abstractyes

Explore more

Same venueBMJ OpenSame topicAcute Kidney Injury ResearchFrench-language works237,207